Real-world use of nirmatrelvir–ritonavir in outpatients with COVID-19 during the
- Real-world use of nirmatrelvir–ritonavir in outpatients with COVID-19 during the era of omicron variants including BA.4 and BA.5 in Colorado, USA: a retrospective cohort study The Lancet
- Comparison of pre- and post-Omicron disease severity among unvaccinated people without risk factors News-Medical.Net
- Real-world effectiveness of nirmatrelvir–ritonavir against BA.4 and BA.5 omicron SARS-CoV-2 variants The Lancet
- View Full Coverage on Google News
Read More: Real-world use of nirmatrelvir–ritonavir in outpatients with COVID-19 during the